NOVARTIS AG (NVSEF)
Clinical trial NCT07117214 updates: 1. completion date: 2028-12-11 → 2029-01-26 2. primary completion date: 2028-12-11 → 2029-01-26
Clinical trial NCT07117214 updates: 1. completion date: 2028-12-11 → 2029-01-26 2. primary completion date: 2028-12-11 → 2029-01-26
📉 **NEGATIVE** • Medium confidence analysis (65%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical